Dr. Gudrun Stengel, CEO and co-founder of Alida Biosciences, shares how her team is unlocking the biology of RNA modifications with next-generation epigenetic tools. In this podcast hosted by ThermoFisher Scientific, she explains the science behind AlidaBio’s EpiPlex™ and EpiScout™ platforms. Tune in for insights on startup life, the future of RNA therapeutics, and the promise of multiomic discovery.
